Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Mallinckrodt
US Department of Justice
Boehringer Ingelheim
Queensland Health
McKinsey
Accenture
Daiichi Sankyo
Healthtrust

Generated: June 18, 2018

DrugPatentWatch Database Preview

THYRO-BLOCK Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Thyro-block, and what generic alternatives are available?

Thyro-block is a drug marketed by Meda Pharms and is included in one NDA.

The generic ingredient in THYRO-BLOCK is potassium iodide. There are two hundred and thirty-five drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the potassium iodide profile page.
Summary for THYRO-BLOCK
Drug patent expirations by year for THYRO-BLOCK
Synonyms for THYRO-BLOCK
106449-25-6
1C4QK22F9J
39448-53-8
59216-96-5
61456-02-8
7681-11-0
AB01274864-01
AB01568251_01
AB1002916
AC1L1J5K
AC1Q1TQ8
AC1Q1TQM
ACMC-1BDBB
AI3-52931
AK-77278
AKOS015833375
AKOS016371890
ANW-46028
Asmofug E
C08219
CAS-7681-11-0
Caswell No. 694
CCRIS 8168
CHEBI:8346
CHEMBL1141
CTK2H7533
D01016
D02URS
DB06715
DSSTox_CID_14836
DSSTox_GSID_34836
DSSTox_RID_79208
DTXSID7034836
EINECS 231-659-4
EPA Pesticide Chemical Code 075701
FT-0645116
HMS3651G04
HSDB 5040
I14-102509
IN002052
IN016883
IN2918
Iodine Solution, 0.1N (N/10)
iodopotassium
Iodure de potassium
Iosat
Joptone
K1-N
Kali iodide
Kalii iodidum
Kalium iodatum
Kaliumiodid
KB-59821
Kisol
Knollide
KS-000002OZ
KSC377K3H
LS-3213
LS41972
LT03329030
Mercuric and potassium iodide solution
MFCD00011405
MolPort-000-158-373
Mudrane Tablets
Mudrane-2 Tablets
NCGC00257542-01
Nesslers Reagent Solution
NLKNQRATVPKPDG-UHFFFAOYSA-M
NSC 77362
NSC-77362
NSC77362
P1721
Pima
potasium iodide
Potassium diiodide
potassium iodid
potassium iodide
Potassium iodide (JP17/USP)
Potassium iodide (K(I2))
Potassium iodide (K2I2)
Potassium iodide (K3I3)
Potassium iodide (KI)
Potassium iodide [JAN]
Potassium iodide [USP:JAN]
Potassium Iodide Neutral ACS
Potassium iodide solution
Potassium iodide solution, 15 % (w/v)
potassium iodide ts
Potassium Iodide USP/FCC
Potassium iodide, >=99.99% trace metals basis
Potassium iodide, >1 - 3% in a non hazardous diluent
Potassium iodide, >3 - 25% in a non hazardous diluent
Potassium iodide, 99% 50g
POTASSIUM IODIDE, ACS
Potassium iodide, ACS reagent
Potassium iodide, ACS reagent, >=99.0%
Potassium iodide, anhydrous, beads, -10 mesh, 99.998% trace metals basis
Potassium iodide, anhydrous, free-flowing, Redi-Dri(TM), ACS reagent, >=99%
Potassium iodide, anhydrous, free-flowing, Redi-Dri(TM), ReagentPlus(R), 99%
Potassium iodide, AR, >=99.8%
Potassium iodide, BioUltra, >=99.5% (AT)
Potassium iodide, BioXtra, >=99.0%
Potassium iodide, JIS special grade, >=99.5%
Potassium iodide, LR, >=99%
Potassium iodide, plant cell culture tested
Potassium iodide, Puratronic
Potassium iodide, puriss. p.a., ACS reagent, >=99.0% (AT)
Potassium iodide, puriss. p.a., reag. ISO, reag. Ph. Eur., >=99.5%
Potassium iodide, puriss., meets analytical specification of Ph.??Eur. BP, USP, 99.0-100.5% (calc. to the dried substance)
Potassium iodide, purum p.a., >=99.0% (AT)
Potassium iodide, ReagentPlus(R), 99%
Potassium iodide, SAJ first grade, >=99.5%
Potassium Iodide, secondary pharmaceutical standard; traceable to USP
Potassium iodide, suitable for oxidant determination, >=99.5%
Potassium iodide, tested according to Ph.Eur.
Potassium iodide, ultra dry
Potassium iodide, United States Pharmacopeia (USP) Reference Standard
Potassium iodide, Vetec(TM) reagent grade
potassium ion iodide
Potassium monoiodide
Potassium salt of hydriodic acid
potassium-iodide
potassiumiodide
Potide
RP22855
RTC-063831
s1897
SC-18247
TC-063831
Thyroblock (TN)
Thyrosafe
Thyroshield
TL8005264
Tox21_301293
TRA-0206473
Tripotassium triiodide
Tyn mans
UNII-1C4QK22F9J
WLN: KA I
Y-9233

US Patents and Regulatory Information for THYRO-BLOCK

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Meda Pharms THYRO-BLOCK potassium iodide TABLET;ORAL 018307-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Deloitte
UBS
Harvard Business School
Medtronic
Teva
McKinsey
Fish and Richardson
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.